Reducing Barriers to Drug Abuse Treatment Services (RBP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00273845|
Recruitment Status : Completed
First Posted : January 9, 2006
Last Update Posted : February 24, 2009
|Condition or disease||Intervention/treatment||Phase|
|Substance Abuse||Behavioral: Motivational interviewing Behavioral: Strengths-Based Case Management||Phase 2 Phase 3|
The Specific Aims of the project are:
- To conduct a detailed qualitative/ethnographic investigation to study: (a) the processes and factors operant in a person's decision to link with a substance abuse treatment agency once a formal (i.e., professional) assessment and referral have been made; and (b) the processes and factors operant in staying in treatment once it has been initiated.
- To identify and classify, using quantitative methods, the operant barriers to treatment linkage and engagement. We will assess the factors that are associated with these barriers and examine the effects of the study's interventions on removing them.
- To evaluate the effectiveness, using a controlled trial, of a Motivational Intervention and Strengths-Based Case Management, compared to the CIU's "standard" referral process, by examining differences between the Standard, Motivational Intervention, and Case Management conditions on treatment linkage and engagement outcomes. The conceptual framework for this controlled trial is the well-studied Andersen model of access and health service use, modified for chemical dependency services (Andersen, 1995). The interventions are designed to affect mutable factors such as perceived barriers to treatment. Data will be collected at baseline, and at 3 and 6 months thereafter. Analyses will examine whether the interventions work better with different groups of clients (e.g. cocaine users versus marijuana users, males versus females, different ethnicities, etc); as well as different treatment modalities (standard outpatient versus intensive outpatient.)
- To conduct a quantitative investigation of the effects of Individual Level and Health Care System Level factors that predict treatment linkage and engagement in the context of the proposed interventions. This study component will develop comprehensive models to predict how these factors interact with the study's interventions to effect treatment linkage and treatment engagement.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||678 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Reducing Barriers to Drug Abuse Treatment Services|
|Study Start Date :||May 2003|
|Actual Primary Completion Date :||May 2008|
|Actual Study Completion Date :||May 2008|
One session of motivational interviewing
Behavioral: Motivational interviewing
Five sessions of strengths-based case management
Behavioral: Strengths-Based Case Management
- Linkage and Retention in substance abuse treatment [ Time Frame: 3 months, 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00273845
|United States, Ohio|
|Dayton, Ohio, United States, 45345|
|Principal Investigator:||Richard C Rapp, M.S.W.||Boonshoft School of Medicine, Wright State University|